Jennifer Armstrong
Psychiatric/Mental Health · Saint Louis, MONPI 1952133506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 316 payments — averaging $24.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$882
- AbbVie$835
- E.r. Squibb & Sons, L.L.C.$696
- Harmony Biosciences LLC$641
- Teva Pharmaceuticals USA, Inc.$615
- plus $3K from 16 others
What the payments were for
- Food & beverage$7,588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 53 | $1,186 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $882 |
| AbbVie | 25 | $835 |
| E.r. Squibb & Sons, L.L.C. | 18 | $696 |
| Harmony Biosciences LLC | 23 | $641 |
| Teva Pharmaceuticals USA, Inc. | 39 | $615 |
| Vanda Pharmaceuticals Inc. | 28 | $565 |
| Supernus Pharmaceuticals, Inc. | 25 | $514 |
| Tris Pharma Inc | 10 | $300 |
| Neurocrine Biosciences, Inc. | 10 | $263 |
| Luye Pharma (USA) Ltd. | 5 | $202 |
| Axsome Therapeutics, Inc. | 10 | $197 |
| Ironshore Pharmaceuticals Inc. | 10 | $178 |
| Acadia Pharmaceuticals Inc | 3 | $165 |
| Biogen | 1 | $117 |
| Johnson & Johnson | 7 | $93 |
| Noven Therapeutics, LLC | 3 | $50 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Indivior Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Braeburn Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$991
- ARISTADA$922
- COBENFY$505
- VRAYLAR$492
- UZEDY$244
- Fanapt$236
- ARISTADA INITIO$230
- CAPLYTA$229
- QELBREE$125
- ERZOFRI EXTENDED-RELEASE$123
- NUPLAZID$123
- INGREZZA$119
- Zurzuvae$117
- Dyanavel XR$110
- Quillivant$110
- Quillichew ER$110
How this compares
$7,588 in reported general payments places this provider in the 90th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatric/mental health in Saint Louis
- Aldijana SacicSaint Louis$510K
- Julie WaterburySaint Louis$135K
- Melinda SmithSaint Louis$13K
- Richard YakimoSaint Louis$10K
- Yevgeniya MykhaylevskaSaint Louis$9K
- Anastasia AmiramovaSaint Louis$9K
- Jessica BurichSaint Louis$8K
- Bonnie HuffSaint Louis$7K
- Jacqueline KirkSaint Louis$6K
- Danielle RoncoSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.